Behavioral Health Group

Name

Behavioral Health Group

Legal name

BHG Holdings, LLC

Website

https://bhgrecovery.com

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

1,001–5,000 employees

Ownership category

akta.pro rank

Product category

Outpatient Opioid Addiction Treatment Services

NAICS

Outpatient Mental Health and Substance Abuse Centers (621420), Outpatient Mental Health and Substance Abuse Centers (62142)

SIC

Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Medication-Assisted Treatment (MAT) & Opioid Treatment Programs (OTPs) (HLAFACAG)

akta.pro secondary industries

Outpatient Substance Use Treatment Programs (IOP/PHP/OP) (HLAFACAF), Outpatient Substance Use Disorder (SUD) Treatment Programs (HLAFABAD)

Keywords

• Opioid addiction treatment
• Medication-assisted treatment
• Outpatient substance abuse
• Behavioral health services
• Addiction recovery care

Headquarters

HQ city

Dallas

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Insurance Reimbursement: Revenue generated through reimbursement from Medicaid, Medicare, and commercial insurance plans for outpatient addiction treatment services including medications, counseling, and support services.
2. Self-Pay Revenue: Flexible self-pay plans for patients without insurance coverage. Treatment is often less expensive than inpatient programs due to the outpatient model.
3. Grant Funding: Grant funding available in many states to help cover treatment costs for eligible patients without insurance.

Pricing tiers

Go-to-market motion2 records

Distribution channels6 records

Marketing channels4 records

Core offering

Behavioral Health Group provides outpatient opioid use disorder (OUD) treatment through a medication-assisted treatment (MAT) model that combines FDA-approved medications with addiction counseling, behavioral therapy, and recovery support services. Services are delivered across a network of 110+ treatment centers and via telehealth, with same-day access and integrated treatment for co-occurring disorders.

Product overview

Behavioral Health Group (BHG) operates a unified outpatient addiction treatment platform centered on Medication-Assisted Treatment (MAT) — combining FDA-approved medications (methadone, buprenorphine/Suboxone, naltrexone/Vivitrol) with individual and group counseling, an Intensive Outpatient Program (IOP), and wraparound recovery support services (case management, peer support, telehealth). The company runs 110+ Joint Commission-accredited outpatient centers across 20+ U.S. states, offering specialized treatment tracks for opioids (fentanyl, heroin, prescription opioids), emerging substances (Kratom, 7-OH, Tianeptine/Tianaa), and co-occurring mental health disorders. BHG also provides structured partner referral services for healthcare providers, criminal justice systems, hospitals, and community organizations, with a secure HIPAA-compliant referral portal enabling coordinated patient intake. The portfolio is organized as a single integrated care model, with IOP and telehealth serving as supplemental program tiers within the same treatment framework.

Differentiator

Problem solved

Functional benefit

Products and services

• Outpatient Opioid Use Disorder Treatment Comprehensive outpatient treatment program for adults with opioid use disorder, combining FDA-approved medication-assisted treatment with counseling, behavioral therapy, and recovery support, delivered across 110+ centers and via telehealth with same-day access.
• Medication-Assisted Treatment (MAT) Evidence-based MAT program using FDA-approved medications combined with counseling and behavioral therapies to treat opioid dependence and support long-term recovery.
• Addiction Counseling Individual and group counseling services delivered alongside MAT, focused on the behavioral components of opioid addiction and recovery.
• Intensive Outpatient Program (IOP) Higher-intensity outpatient program for patients who need more structured clinical support than standard MAT, while remaining in an outpatient setting.
• Telehealth Addiction Treatment Virtual delivery of medication-assisted treatment and counseling for opioid use disorder, enabling remote patient access to BHG clinical services.
• Patient Referral Program HIPAA-compliant program for healthcare providers, hospitals, emergency departments, and community partners to refer opioid use disorder patients to BHG's treatment network through an online referral portal.
• Criminal Justice Treatment Services Specialized outpatient OUD treatment program designed for individuals referred from criminal justice, probation, parole, and reentry programs.
• Co-Occurring Disorder Treatment Integrated treatment for patients with opioid use disorder alongside co-occurring mental health or other substance use conditions, delivered through BHG's whole-person care model.

Quantifiable outcome

• 92% of patients report improved quality of life
• +7 more outcomes

Named customers2 records

Segments8 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Two partnerships are on record, tiered major.

• Center for Behavioral Health (CBH)majorStrategic or Co-development Partner · 13 January 2022BHG announced the acquisition of Center for Behavioral Health (CBH), expanding its outpatient substance use disorder treatment services across 23 states in the US. This strategic move aims to address the growing opioid crisis and increase access to comprehensive recovery programs.
• Meridian Behavioral Health, LLC (Valhalla Place)majorStrategic or Co-development Partner · 4 November 2021BHG expanded into Minnesota through the acquisition of four Valhalla Place opioid treatment centers operated by Meridian Behavioral Health, LLC. The acquisition aims to address the high need for addiction treatment services in Minnesota, with Valhalla Place treating over 3,000 patients and employing 185 staff. BHG plans to implement its proprietary care model across these locations.

Scale indicators11 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• BayMark Health Services: BayMark is the most directly comparable US outpatient opioid treatment provider, operating a multi-state network of OTPs delivering methadone, buprenorphine, and naltrexone with counseling — explicitly mentioned alongside BHG as a co-marketed major SUD treatment asset.
• CleanSlate Centers: CleanSlate operates a multi-state outpatient network providing office-based MAT (primarily buprenorphine) with counseling and wraparound services, directly competing with BHG for the same outpatient SUD patient population.
• Ideal Option: Ideal Option is a multi-state outpatient MAT provider offering buprenorphine and Suboxone-based treatment with counseling; it competes with BHG in the office-based opioid treatment segment across the western and central US.
• BrightView Health: BrightView operates outpatient addiction treatment centers across multiple states offering MAT, counseling, IOP, and case management — closely aligned with BHG's integrated outpatient SUD service model.
• Spectrum Health Systems: Spectrum Health Systems operates outpatient and residential addiction treatment programs across New England and beyond, including methadone and buprenorphine services, and is frequently referenced alongside BHG as a regional multi-modality SUD provider.

Broad incumbents

• Acadia Healthcare: Acadia is a large publicly traded behavioral health operator running inpatient psychiatric facilities and residential treatment programs; its broader portfolio overlaps with BHG's SUD treatment scope but does not specialize in outpatient OTPs.
• American Addiction Centers: American Addiction Centers runs a national network of inpatient and outpatient addiction treatment facilities; it overlaps with BHG on outpatient MAT and counseling but has a broader mix of residential and detox services.
• Hazelden Betty Ford Foundation: Hazelden Betty Ford is a leading national nonprofit addiction treatment provider with both residential and outpatient programs; it competes for some of the same patients BHG serves while specializing more in higher-acuity residential care.
• Caron Treatment Centers: Caron is a longstanding national addiction treatment operator offering inpatient, outpatient, and MAT services; it overlaps with BHG on outpatient SUD treatment but is anchored by its residential flagship.

Emerging players

• Workit Health: Workit Health is a virtual-first MAT provider offering buprenorphine treatment and counseling via telehealth; it represents the emerging digital entrant that competes with BHG for the same outpatient SUD population through a lower-cost delivery model.

Market position

Strengths5 records

Weaknesses1 record

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/bhgrecovery

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries2 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Behavioral Health Group